MissionIR Articles
-
MissionIRNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Announces Commercial Class 3 EV EPA Certification
Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, has reached a key milestone. The company announced that it has received full approval from the Environmental Protection Agency (“EPA”) with certification for class 3…
-
RVL Pharmaceuticals plc (NASDAQ: RVLP) Looking to Capitalize on UPNEEQ’s Significant Potential
RVL Pharmaceuticals (NASDAQ: RVLP), is a specialty pharmaceutical company focusing on the commercialization of UPNEEQ(R) (oxymetazoline hydrochloride ophthalmic solution), 0.1%, for the treatment of acquired blepharoptosis (ptosis, or low-lying eyelids) in adults. The company believes…
-
MissionIRNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Receives EPA Certification for Class 3 EV Commercial Vehicles
Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced its achievement of a key milestone with full approval from the Environmental Protection Agency (“EPA”) with certification for Class 3 EV Commercial Vehicles…
-
Trial Enrollment Growth Supports Plans of CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) to Complete Enrollment for Important Brain Cancer Drug Study
Cancer drug developer CNS Pharmaceuticals (NASDAQ: CNSP) is closer to reporting the results of its drive toward a new treatment for the effectively incurable brain cancer glioblastoma (“GBM”), with 200 of the expected 243 patients…
-
MissionIRNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) K5 Security Robot Deployed in NYPD Pilot Program
Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots and blue light emergency communication systems, has announced that the city of New York and the New York Police Department (“NYPD”) launched the Knightscope K5…
-
MissionIRNewsBreaks – Longeveron Inc. (NASDAQ: LGVN) Making Significant Strides to Advance Cellular Therapy Programs
Longeveron (NASDAQ: LGVN) is a clinical-stage biotechnology company developing cellular therapies for life-threatening and chronic conditions such as hypoplastic left heart syndrome (“HLHS”), Alzheimer’s disease and Aging-related Frailty. “The company is guided by the mission…
-
MissionIRNewsBreaks – RVL Pharmaceuticals plc (NASDAQ: RVLP) Anticipating Growing Demand for UPNEEQ(R)
RVL Pharmaceuticals (NASDAQ: RVLP) is a a specialty pharmaceutical company whose near-term focus is to continue the rollout of UPNEEQ(R) into the medical aesthetics market through its dedicated sales force. “UPNEEQ(R) is the first non-surgical…
-
MissionIRNewsBreaks – Why PaxMedica Inc. (NASDAQ: PXMD) Is ‘One to Watch’
PaxMedica (NASDAQ: PXMD) is a clinical stage biopharmaceutical company focusing on the development of novel anti-purinergic therapies (“APTs”) for the treatment of autism spectrum disorder (“ASD”) and other serious conditions with intractable neurologic symptoms. “The…
-
MissionIRNewsBreaks – Fintech Ecosystem Development Corp. (NASDAQ: FEXD) Carving out Share in Challenger Bank, Crypto Markets
Fintech Ecosystem Development Corp. (NASDAQ: FEXD), through strategic mergers and acquisitions, is helping to accelerate the growth of the challenger bank market. “In turn, the company is making financial services affordable and accessible, particularly to…
-
MissionIRNewsBreaks — Cepton Inc. (NASDAQ: CPTN) CCO Talks Industrializing Lidar with Automotive Programs, Company’s Reverse Stock Split Takes Effect
Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance lidar solutions, is in the spotlight. Cepton’s new chief commercial officer Mitch Hourtienne was a guest during a recent Proactive Investors interview. During the interview,…
-
MissionIRNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces New Studies to Examine DehydraTECH(TM)-Powered GLP-1 Drugs
Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced its intention to launch new human and animal studies to examine DehydraTECH(TM)-processed glucagon-like peptide-1 (“GLP-1”) drugs such as, but not limited…
-
MissionIRNewsBreaks – SuperCom Ltd. (NASDAQ: SPCB) Announces New National Program with Finnish Government
SuperCom (NASDAQ: SPCB), a global provider of secured solutions for the e-government, Internet of Things (“IoT”), and cybersecurity sectors, has secured a new national program with the government of Finland. According to the announcement, the…
-
MissionIRNewsBreaks – Mullen Automotive Inc.’s (NASDAQ: MULN) Cargo Vans Purchased by NYPA on Heels of Successful EV Pilot
Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced that the New York Power Authority (“NYPA”) has purchased the company’s campus delivery cargo vans after successful completion of an EV pilot program…
-
MissionIRNewsBreaks – Near Intelligence Inc. (NASDAQ: NIR) Bringing High-Quality Real Estate Analytics to Leading CRE Companies
Near Intelligence (NASDAQ: NIR) is a global data intelligence platform that curates one of the world’s largest sources of intelligence on people and places. The company today announced its positioning as a trusted partner of…
-
Lexaria Bioscience Corp. (NASDAQ: LEXX) to Demonstrate DehydraTECH-CBD Benefits in Upcoming Investigational New Drug Application Submission
Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, remains on track for its upcoming Investigational New Drug (“IND”) submission. The application is for the company’s planned US Phase 1b Hypertension Clinical Trial…
-
MissionIRNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Announces 100th Landing of Its Robot Show
Knightscope (NASDAQ: KSCP) is a leading developer of autonomous security robots (“ASRs”) and blue light emergency communication systems. The company has announced its 100th Robot Roadshow landing that will take place on Oct. 3, 2023,…
-
MissionIRNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Building Protection and Powerful IP Portfolio for Its Diabetes Gene Therapy Program
Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing treatments for patients with cancer and diabetes, recently announced its entry into an exclusive license agreement related to a particular gene therapy for…
-
Renovaro BioSciences Inc. (NASDAQ: RENB) Targets Pancreatic Cancer Solution Through Work With GEDI Cube AI Platform, NVIDIA Resources
Pre-clinical biotechnology innovator Renovaro BioSciences (NASDAQ: RENB) is seeking solutions for hard-to-treat cancers and other illnesses through the use of a proprietary cell and gene solution designed to promote immune system response. The company has…
Search Articles
Latest Articles
- MissionIRNewsBreaks – MindWave Innovations Inc. (NYSE American: APUS) Offers Secure Gateway to Digital Assets
- VERAXA Biotech AG (NASDAQ: VRXA) Advances BiTAC-ADC Platform as It Expands Next-Generation Cancer Therapy Pipeline
- MissionIRNewsBreaks – Greenland Energy Company (NASDAQ: GLND) Advances Jameson Land Basin Toward Exploration Drilling
- MissionIRNewsBreaks – Massimo Group (NASDAQ: MAMO) Terminates Proposed FST Acquisition, Refocuses on Internal Security Technology Development
- MissionIRNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Advances Lucid-MS Toward Phase 2 Trials for Multiple Sclerosis